PHM and ODAIA Partner to Advance AI-Driven HCP Engagement in Life Sciences

PHM and ODAIA Partner to Advance AI-Driven HCP Engagement in Life Sciences

PR Newswire

Partnership brings ODAIA’s commercial intelligence platform, combined with PHM’s health media expertise, to leading health brands in the U.S., establishing a new standard for engagement of healthcare professionals

NEW YORK, Nov. 17, 2026 /PRNewswire/ — PHM, the leading health media agency in the U.S. and part of Publicis Groupe, today announced a partnership and strategic investment in ODAIA, an AI company delivering predictive commercial intelligence in pharma. PHM has also been named ODAIA’s exclusive agency partner in the U.S.

PHM and ODAIA announce partnership

PHM will bring the ODAIA platform to pharmaceutical brands to advance coordination of digital media and field sales for healthcare professionals (HCP). PHM’s investment anchors ODAIA’s Series C funding, which ODAIA announced today.

The investment reflects PHM’s continued focus on bringing innovative AI-driven capabilities to clients and expanding the tools available to improve commercial effectiveness across the healthcare ecosystem. ODAIA’s commercial intelligence platform gives brand, marketing and field teams a single view of each HCP, bringing together prescribing data, field sales activity and digital engagement.

Through the partnership, media can be more closely coordinated against the same HCP-level priorities that guide brand field teams with digital and live touchpoints sequenced for each physician. ODAIA’s predictive AI identifies physicians whose patients are likely to need a therapy, often months before a diagnosis appears in the data, and automates HCP engagement by determining which physicians to prioritize, through which channels, and with what message.

For pharmaceutical marketers, this creates an opportunity to move beyond channel-level insights and better understand the broader context of an HCP’s engagement with a brand. By applying AI and machine learning to these signals, brands can identify patterns in HCP behavior and use those insights to provide more relevant messages, automatically activated and sequenced across channels.

“Pharmaceutical commercial teams have more data and more ways to engage HCPs than ever before, but that data is often fragmented across functions and channels,” said Stephen Farquhar, CEO, PHM. “Our clients are looking for smarter ways to connect fragmented commercial data and create more meaningful engagement with HCPs. Our investment in ODAIA and our exclusive agency partnership brings together AI, data and media capabilities to do so. By delivering more relevant messages to HCPs when they are most receptive, we take meaningful steps to get the right medicines in the hands of patients that need them.”

“ODAIA was built to help pharmaceutical companies turn complex commercial data into actionable intelligence, and that is the work we do every day alongside brand and field teams at leading pharmaceutical companies,” said Philip Poulidis, CEO, ODAIA. “This partnership with PHM can help more pharma brands understand HCP behavior and act on it with confidence.”

About PHM

PHM is the leading health media agency in the U.S., built to transform how brands connect with people across today’s complex healthcare landscape. By bringing together data, content and creativity, PHM redefines what media can do for healthcare brands. PHM partners with pharmaceutical, biotech, hospital systems, and health and wellness companies to create data-driven, omnichannel media strategies that connect brands with HCPs and patients at every stage of the care journey.

About ODAIA

ODAIA is the leading AI company delivering predictive commercial intelligence for pharma. Leading biopharmaceutical companies, from top-20 global organizations to specialty innovators, use ODAIA to uncover missed Rx opportunities, determine which HCPs to prioritize through which channels, and coordinate true omnichannel execution across sales and marketing. By continuously turning HCP and patient signals into real-time actions, ODAIA enables commercial teams to adapt strategy as markets change and activate updated guidance directly within the systems they already use.

Media Contact: Emily Honig, Emily.Honig@phm.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/phm-and-odaia-partner-to-advance-ai-driven-hcp-engagement-in-life-sciences-302939058.html

SOURCE PHM